Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Which Pharma Firm Increases US Prices The Most?

Executive Summary

Transparency reports from companies aim to change conversation from prices to discounts, but also invite comparisons. Lilly, for example, saw a higher average list price increase in 2016 than Merck and Janssen, but its net prices grew by less than the others.

Advertisement

Related Content

Just Trust Me: Most Firms Unwilling To Publicly Pledge Pricing Restraint
Insulin Pricing, PBM Relationships Under Government Microscope
Who Speaks For The White House On Drug Prices? Industry Better Hope It Is Not Donald Trump
Where Will It End? Lilly’s US Price Concessions Increase 30% In 2016
Janssen's Drug Pricing Report Emphasizes Value Of Rebates
Lilly’s Insulin Discounts Target High-Deductible Insurance Gaps
Pharma Pricing, Non-Profit Ties Get Increasing Scrutiny From Prosecutors

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS120260

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel